These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 26843154

  • 1. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
    Hazim S, Curtis PJ, Schär MY, Ostertag LM, Kay CD, Minihane AM, Cassidy A.
    Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
    [Abstract] [Full Text] [Related]

  • 2. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
    Liu ZM, Ho SC, Chen YM, Xie YJ, Huang ZG, Ling WH.
    BMC Complement Altern Med; 2016 Mar 01; 16():89. PubMed ID: 26928904
    [Abstract] [Full Text] [Related]

  • 3. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL, Vafeiadou K, Hallund J, Bügel S, Koebnick C, Reimann M, Ferrari M, Branca F, Talbot D, Dadd T, Nilsson M, Dahlman-Wright K, Gustafsson JA, Minihane AM, Williams CM.
    Am J Clin Nutr; 2005 Dec 01; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [Abstract] [Full Text] [Related]

  • 4. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM, Ho SC, Chen YM, Tomlinson B, Ho S, To K, Woo J.
    Eur J Clin Nutr; 2015 Oct 01; 69(10):1161-8. PubMed ID: 25782428
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM, Ho SC, Woo J, Chen YM, Wong C.
    Menopause; 2014 Jun 01; 21(6):653-60. PubMed ID: 24149925
    [Abstract] [Full Text] [Related]

  • 6. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y, Uehara M, Abe F, Kimira Y, Ishimi Y.
    Nutr J; 2013 Sep 13; 12():127. PubMed ID: 24034304
    [Abstract] [Full Text] [Related]

  • 7. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
    Sekikawa A, Wharton W, Butts B, Veliky CV, Garfein J, Li J, Goon S, Fort A, Li M, Hughes TM.
    Int J Mol Sci; 2022 Oct 07; 23(19):. PubMed ID: 36233223
    [Abstract] [Full Text] [Related]

  • 8. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK, Barnes S, Krontiras H, Nagy TR.
    Nutr Res; 2014 Feb 07; 34(2):116-25. PubMed ID: 24461312
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Equol production capability is associated with favorable vascular function in postmenopausal women using tibolone; no effect with soy supplementation.
    Törmälä R, Appt S, Clarkson TB, Groop PH, Rönnback M, Ylikorkala O, Mikkola TS.
    Atherosclerosis; 2008 May 07; 198(1):174-8. PubMed ID: 17961576
    [Abstract] [Full Text] [Related]

  • 13. Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.
    van der Velpen V, Geelen A, Hollman PC, Schouten EG, van 't Veer P, Afman LA.
    Am J Clin Nutr; 2014 Nov 07; 100(5):1269-77. PubMed ID: 25332325
    [Abstract] [Full Text] [Related]

  • 14. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
    van der Velpen V, Hollman PC, van Nielen M, Schouten EG, Mensink M, Van't Veer P, Geelen A.
    Eur J Clin Nutr; 2014 Oct 07; 68(10):1141-7. PubMed ID: 24939433
    [Abstract] [Full Text] [Related]

  • 15. Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Daily JW, Ko BS, Ryuk J, Liu M, Zhang W, Park S.
    J Med Food; 2019 Feb 07; 22(2):127-139. PubMed ID: 30592686
    [Abstract] [Full Text] [Related]

  • 16. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM, Ho SC, Chen YM, Ho S, To K, Tomlinson B, Woo J.
    Mol Nutr Food Res; 2014 Apr 07; 58(4):709-17. PubMed ID: 24273218
    [Abstract] [Full Text] [Related]

  • 17. Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial.
    Curtis PJ, Potter J, Kroon PA, Wilson P, Dhatariya K, Sampson M, Cassidy A.
    Am J Clin Nutr; 2013 May 07; 97(5):936-42. PubMed ID: 23553151
    [Abstract] [Full Text] [Related]

  • 18. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
    deVere White RW, Tsodikov A, Stapp EC, Soares SE, Fujii H, Hackman RM.
    Nutr Cancer; 2010 May 07; 62(8):1036-43. PubMed ID: 21058191
    [Abstract] [Full Text] [Related]

  • 19. Effect of whole soy and purified isoflavone daidzein on renal function--a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension.
    Liu ZM, Ho SC, Chen YM, Tang N, Woo J.
    Clin Biochem; 2014 Sep 07; 47(13-14):1250-6. PubMed ID: 24877660
    [Abstract] [Full Text] [Related]

  • 20. Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans.
    Zhang X, Veliky CV, Birru RL, Barinas-Mitchell E, Magnani JW, Sekikawa A.
    Nutrients; 2021 Oct 23; 13(11):. PubMed ID: 34835997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.